［1］Xing MZ.BRAF mutation in thyroid cancer［J］.Endocri Rela Cancer，2005,12(2)：245-247.
［2］Sienel W，Polzer B，Elshawi K，et al.Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9［J］.Mod Pathol，2008，21(9)：1130-1138.
［3］Mazzaferri E.Managing small thyroid cancers［J］.JAMA，2006,295(5)：2179-2182.
［4］Troviseo V，Soares P，Preto A，et al.Moleettlar genetics of papillary thyroid carcinoma：great expectation［J］.Arq Bras Endocrinol Metabol，2007，51(5)：643-653.
［5］Nabeshima K，Iwasaki H，Koga K，et al.Emmprin(basigin/CD147)：mateix metalloproteinase modulator and functional cell recognition molecule that plays a critical role in cancer progression［J］.Pathol Int，2006，56（7）：359-367.
［6］Wu Qian,Zhang Hong,Zhang Heping.Investigation of CD147 and MMP-2 expression in gastric carcinoma and their significance by tissue microarry［J］.Acta Universitatis Med Anhui，2010，45(1)：43-46.［吴倩,张红，张和平.组织芯片技术研究CD147和MMP-2在胃癌中的表达［J］.安徽医科大学学报，2010，45(1)：43-46.］
［7］Mi Z,Oliver T,Guo H,et al.Thrombin-cleaved COOH(-)terminal osteopontin peptide binds with cyelophilin C to CD147 in murine breast cancer cells［J］.Cancer Res，2007,67(9)：4088-4097.
［8］Riethdof S，Reimers N，Assmann V，et al.High incidence of EMMPRIN expression in human tumors［J］.Int J Cancer，2006,119(8)：1800-1810.
［9］Zhang Juliang,Yao Qing,Chen Jianghao，et al.Effects of CD147 siRNA on expression of VEGF，MMP-2 and HIF-1α mRNA and apoptosis in breast cancer cells［J］.Mod Oncol,2013,21(2):247-249.［张聚良,姚青,陈江浩,等.CD147 siRNA对乳腺癌细胞HIT-1Αα、MMP-2与VEGF表达及细胞凋亡的影响［J］.现代肿瘤医学,2013,21(2):247-249.］
［10］Dong Yuhong,Li Juan,Zhao Xiaoling.The expression of c-met and CD147 in papillary thyroid carcinoma and its clinical significance［J］.Practical Preventive Med，2012，19(6)：907-909.［董郁红，李隽，赵小玲.C-met 和CD147在甲状腺乳头状癌中的表达及临床意义［J］.实用预防医学，2012，19(6)：907-909.］
［11］Li QQ，Wang WJ，Xu JD，et al.Involvement of CD147 in regulation of multidrug resistance to p-gp substrate drugs and in vitro invasion in breast cancer cells［J］.Cancer Sci，2007，98(7)：1064-1069.
［12］Tang Y，Nakada MT，Kesavan P，et al.Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases［J］.Cancer Res，2005，65(8)：3193-3199.
［13］Liang L，Major T，Bocan T.Characterization of the promoter of human extracellular matrix metalloproteinase inducer(EMMPRIN)［J］.Gene，2002,282(122)：75-86.
［14］Jiang Jianli,Yao Xiying,Zhou Jun,et al.HAb18G/CD147 stimulates MMPs' release and activation in human hepatoma cells［J］.Tumor，2004，24(6)：534-537.［蒋建利,姚西英,周筠,等.HAb18G/CD147刺激人肝癌细胞分泌基质金属蛋白酶的机制探讨［J］.肿瘤，2004，24(6)：534-537.］
［15］Guo Minying，Xing Yonggang，Chen Weiling，et al.bcl-2，p53 and Ki-67 expression in thyroid carcinoma and its clinical significance［J］.Mod Oncol,2014,22(6):1294-1297.［郭民英,邢永刚,陈卫伶,等.bcl-2、p53和Ki-67在甲状腺癌中的表达及其临床意义的研究［J］.现代肿瘤医学,2014,22(6):1294-1297.］